|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 317/30 | |
| C07D 405/04 | |||
| C07D 411/04 | |||
| C07D 307/20 | |||
| C07D 307/33 | |||
| C07H 15/203 | |||
| C07H 19/06 |
| (11) | Patento numeris | 1809301 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05808357.7 |
| Europos patento paraiškos padavimo data | 2005-09-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/032406 |
| Data | 2005-09-13 |
| (87) | Numeris | WO 2006/031725 |
| Data | 2006-03-23 |
| (30) | Numeris | Data | Šalis |
| 609783 P | 2004-09-14 | US | |
| 610035 P | 2004-09-15 | US | |
| 666230 P | 2005-03-29 | US |
| (72) |
CHUN, Byoung-Kwon, US
WANG, Peiyuan, US
DU, Jinfa, US
RACHAKONDA, Suguna, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | 2-FLUORO-2-ALKYL-SUBSTITUTED D-RIBONOLACTONE INTERMEDIATES |
| 2-FLUORO-2-ALKYL-SUBSTITUTED D-RIBONOLACTONE INTERMEDIATES |